Objective: To determine the validity, intra- and inter-rater, and absolute reliability of a return to sport testing battery for the shoulder in a healthy cohort.
Design: Cross-sectional design. All participants completed a battery of strength (isokinetic, isometric, and repetition to failure) and functional assessments on two occasions. Concurrent validity to isokinetic testing was assessed, and intra-rater, inter-rater, and absolute reliability were established for all assessments.
Setting: Controlled clinical environment.
Participants: Thirty healthy adults active in recreational sports participated, mean age 24.0 ± 1.6 years; MAIN OUTCOME MEASURES: Correlations (Pearson's r), reliability (Intraclass Correlation Coefficient), Standard error of the measurement, Minimal detectable change.
Results: Correlations to isokinetic assessments at 60° & 180°/second were moderate to strong for isometric (r: 0.68-0.80) and functional testing (r: 0.55-0.83) and weak for repetition to failure testing (r: 0.37-0.74). All isokinetic (ICC: 0.88-0.94), isometric (ICC: 0.83-0.94), and functional assessments (ICC: 0.80-0.92) had good to excellent intra-rater reliability, while repetition to failure testing had poor to moderate reliability (ICC: 0.48-0.57). The inter-rater reliability of the isometric assessments was moderate to excellent (ICC: 0.71-0.92) across movements. Expressed as a percentage of the mean, the standard error of the measurement ranged from 7% to 25% and the minimal detectable change ranged from 20% to 69% across all assessment methods.
Conclusion: The isokinetic, isometric, and functional assessments used in this return to sports testing battery demonstrates acceptable validity and reliability. Further refinement to the methods used to assess muscular endurance is needed to improve reliability. This study offers clinicians information that can be utilized in clinical decision-making as it relates the testing battery's psychometric properties.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.ptsp.2020.12.003 | DOI Listing |
Compr Psychiatry
December 2024
Laboratory of Behavioral Medicine, Neuroscience Institute, Lithuanian University of Health Sciences, Kaunas-Palanga, Lithuania.
Background: Cardiovascular diseases such as coronary artery disease (CAD) have a high prevalence of psychiatric comorbidities, that may impact clinically relevant outcomes (e.g., cognitive impairment and executive dysfunction).
View Article and Find Full Text PDFPLoS One
January 2025
Julius Kühn-Institut (JKI), Federal Research Centre for Cultivated Plants, Institute for Epidemiology and Pathogen Diagnostics, Rodent Research, Muenster, Germany.
Small rodents can cause problems on farms such as infrastructure damage, crop losses or pathogen transfer. The latter threatens humans and livestock alike. Frequent contacts between wild rodents and livestock favour pathogen transfer and it is therefore important to understand the movement patterns of small mammals in order to develop strategies to prevent damage and health issues.
View Article and Find Full Text PDFAlzheimers Dement
December 2024
German Center for Neurodegenerative Diseases (DZNE), Bonn, North Rhine-Westphalia, Germany.
Background: MicroRNAs have been linked to dementia. However, understanding their relation to cognition in the general population is required to determine their potential use for the detection and prevention of age-associated cognitive decline and preclinical dementia. Therefore, we examined the association of circulating microRNAs with cognitive performance in a population-based cohort and the possible underlying mechanisms.
View Article and Find Full Text PDFAlzheimers Dement
December 2024
Salk Institute for Biological Studies, La Jolla, CA, USA.
Background: As humans age, some experience cognitive impairment while others do not. When impairment occurs, it varies in severity across individuals. Translationally relevant models are critical for understanding the neurobiological drivers of this variability, which is essential to uncovering the mechanisms underlying the brain's susceptibility to aging.
View Article and Find Full Text PDFAlzheimers Dement
December 2024
Rutgers University-Newark, Newark, NJ, USA.
Background: Alzheimer's disease (AD) is sometimes characterized as "type 3 diabetes" because hyperglycemia impairs cognitive function, particularly in the medial temporal lobe (MTL) and prefrontal regions. Further, both AD and type 2 diabetes (T2D) disproportionately impact African Americans. Although people with T2D are generally suggested to have lower episodic memory and executive function, limited data exist in older African Americans.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!